Compass Pathways PLC

CMPS

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2025

    Employees

    166

Stocks News & Analysis

stocks

Progress in UK expansion for undervalued ASX share

Guidance reaffirmed and UK implementation on track.
stocks

The sectors set to soar on government spending

Governments worldwide love to spend more money, and there are no signs that it will change any time soon.
stocks

Chart of the Week: How private companies are reshaping public markets

Our latest take from the US Manager Research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,098.609.70-0.11%
CAC 408,032.1142.12-0.52%
DAX 4024,031.8017.94-0.07%
Dow JONES (US)47,311.00225.760.48%
FTSE 1009,751.0126.07-0.27%
HKSE26,485.90550.492.12%
NASDAQ23,499.80151.160.65%
Nikkei 22550,883.68671.411.34%
NZX 50 Index13,576.8144.17-0.32%
S&P 5006,796.2924.740.37%
S&P/ASX 2008,828.308.50-0.10%
SSE Composite Index4,007.7638.510.97%

Market Movers